Cross-linked mitochondrial targeting doxorubicin liposome and preparation method thereof
A technology of doxorubicin lipid and mitochondria, which is applied in the field of anti-tumor drug liposome and its preparation, can solve the problems of affecting anti-tumor effect, low carrier uptake rate, neurotoxicity, etc., and achieve good tumor tissue targeting, Avoid early release, long cycle effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] The doxorubicin liposome described in this example is composed of doxorubicin, soybean lecithin, cholesterol and cross-linkable mitochondria-targeting pegylated distearoylphosphatidylethanolamine (DSPE-PEG2000-KLA). The mass ratio of doxorubicin hydrochloride to soybean lecithin is 1:5. The molar ratio of soybean lecithin, cholesterol and DSPE-PEG2000-KLA is 50:47:3, and the structural formula of the DSPE-PEG2000-KLA is
[0040]
[0041] The preparation method is as follows:
[0042] (1) Preparation of DSPE-PEG2000-KLA
[0043] Distearoylphosphatidylethanolamine-polyethylene glycol 2000-maleimide (DSPE-PEG2000-Mal), polypeptide D-(KLAKLAK) 2 -C 5 And triethylamine as raw material, polypeptide D-(KLAKLAK) 2 -C 5 , triethylamine, the mol ratio of DSPE-PEG2000-Mal is 1:1:1;
[0044] Under nitrogen protection, DSPE-PEG2000-Mal, triethylamine and chloroform were mixed uniformly to obtain the first solution, and the amount of chloroform was such that the concentratio...
Embodiment 2
[0050] The doxorubicin liposome described in this example is composed of doxorubicin, egg yolk lecithin, cholesterol and mitochondria-targeted pegylated dimyristoylphosphatidylethanolamine (DMPE-PEG2000-KLA). The mass ratio of doxorubicin hydrochloride to egg yolk lecithin is 1:20. The molar ratio of egg yolk lecithin, cholesterol and DMPE-PEG2000-KLA is 90:2:8, and the structural formula of DMPE-PEG2000-KLA is
[0051]
[0052] The preparation method of described liposome is as follows:
[0053] (1) Preparation of DMPE-PEG2000-KLA
[0054] Dimyristoylphosphatidylethanolamine-polyethylene glycol 2000-maleimide (DMPE-PEG2000-Mal), polypeptide D-(KLAKLAK) 2 -C 5 And 4-dimethylaminopyridine as raw material, polypeptide D-(KLAKLAK) 2 -C 5 , 4-dimethylaminopyridine, the mol ratio of DMPE-PEG2000-Mal is 2:2:1;
[0055] Under nitrogen protection, mix DMPE-PEG2000-Mal, 4-dimethylaminopyridine, and dichloromethane evenly to obtain the first solution. The amount of dichlorometh...
Embodiment 3
[0061] The doxorubicin liposome described in this example is composed of doxorubicin, hydrogenated lecithin, cholesterol and mitochondria-targeted pegylated dipalmitoylphosphatidylethanolamine (DPPE-PEG2000-KLA). The mass ratio of the doxorubicin hydrochloride to the hydrogenated lecithin is 1:10. The molar ratio of hydrogenated lecithin, cholesterol and DPPE-PEG2000-KLA is 70:25:5, and the structural formula of DPPE-PEG2000-KLA is
[0062]
[0063] (1) Preparation of DPPE-PEG2000-KLA
[0064] Dipalmitoylphosphatidylethanolamine-polyethylene glycol 2000-maleimide (DPPE-PEG2000-Mal), polypeptide D-(KLAKLAK) 2 -C 5 And N, N-diisopropylethylamine as raw material, polypeptide D-(KLAKLAK) 2 -C 5 , N, the molar ratio of N-diisopropylethylamine, DPPE-PEG2000-Mal is 3:3:1;
[0065] Under the protection of nitrogen, mix DPPE-PEG2000-Mal, N,N-diisopropylethylamine, and dichloromethane evenly to obtain the first solution. The amount of dichloromethane in the first solution is to ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com